ResMed Bull Looking for Masks, Guidance Detail -- Market Talk
ResMed Price Target Raised 4.3% to A$37.80/Share by Macquarie
Is Your Smartwatch Boosting Med Tech Stocks? -- Barrons.com
ResMed Inc Insider Plans Stock Sale
ResMed Inc: ResMed to Report First Quarter Fiscal 2025 Results
ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker. -- Barrons.com
Resmed Inc Reports CDI Fluctuations in September
Is ResMed Inc.'s (NYSE:RMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
ResMed Is Maintained at Buy by B of A Securities
Express News | Resmed Inc : BofA Global Research Raises Price Objective to $270 From $240
ResMed Initiated at Outperform by Baird
Australian Healthcare Players See Wage Indexation Benefits, Margin Expansion in Fiscal 2025, Jarden Research Says
ResMed Inc. (NYSE:RMD) Is a Favorite Amongst Institutional Investors Who Own 74%
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
Why Is the ResMed Share Price Taking a Thumping on Thursday?
ResMed Stock Is S&P 500's Worst Performer. GLP-1 Drugs Are a Risk.
ResMed Price Target Announced at $180.00/Share by Wolfe Research
ResMed Cut to Underperform From Peer Perform by Wolfe Research
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
ResMed Lauds Apple's Sleep Apnoea Detection Feature
No Data
No Data